Plasma 25-hydroxyvitamin D and risk of breast cancer in women followed over 20 years

Experimental evidence supports a protective role of 25-hydroxyvitamin D (25(OH)D) in breast carcinogenesis, but epidemiologic evidence is inconsistent. Whether plasma 25(OH)D interacts with breast tumor expression of vitamin D receptor (VDR) and retinoid X receptor-alpha (RXR) has not been investiga...

Full description

Saved in:
Bibliographic Details
Published in:Cancer Res
Main Authors: Eliassen, A. Heather, Warner, Erica T., Rosner, Bernard, Collins, Laura C., Beck, Andrew H., Quintana, Liza M., Tamimi, Rulla M., Hankinson, Susan E.
Format: Artigo
Language:Inglês
Published: 2016
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5026605/
https://ncbi.nlm.nih.gov/pubmed/27530324
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-16-0353
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items